Eden Research (LON:EDEN) Stock Price Down 13.2% – What’s Next?

Eden Research plc (LON:EDEN)’s share price fell 13.2% on Monday . The company traded as low as GBX 2.26 ($0.03) and last traded at GBX 2.37 ($0.03). 1,775,147 shares changed hands during trading, an increase of 133% from the average session volume of 762,776 shares. The stock had previously closed at GBX 2.73 ($0.04).

Eden Research Stock Performance

The stock has a market cap of £12.27 million, a price-to-earnings ratio of -8.06 and a beta of 0.92. The stock’s 50-day simple moving average is GBX 3.39 and its two-hundred day simple moving average is GBX 3.72. The company has a debt-to-equity ratio of 1.26, a quick ratio of 2.42 and a current ratio of 3.80.

Insider Buying and Selling

In other Eden Research news, insider Lykele van der Broek purchased 256,000 shares of the company’s stock in a transaction on Thursday, February 6th. The shares were bought at an average cost of GBX 4 ($0.05) per share, with a total value of £10,240 ($13,229.97). Also, insider Alexander John Abrey purchased 167,947 shares of the business’s stock in a transaction dated Tuesday, March 4th. The shares were acquired at an average price of GBX 3 ($0.04) per share, with a total value of £5,038.41 ($6,509.57). In the last 90 days, insiders acquired 964,487 shares of company stock valued at $3,690,001. Insiders own 14.02% of the company’s stock.

Eden Research Company Profile

Eden Research is the only UK-listed company focused on biopesticides for sustainable agriculture. It develops and supplies innovative biopesticide products and natural microencapsulation technologies to the global crop protection, animal health and consumer products industries.

Eden’s products are formulated with terpene active ingredients, based on natural plant defence metabolites.